Start Forschung Personen

Personen

apl. Prof. Dr. Mathias Zink

E-Mail

 

Publikationen in peer-reviewed Zeitschriften seit 2006

TOP 5 Publikationen:

  1. Galling B, Roldán A, Hagi K, Rietschel L, Walyzada F, Zheng W, Cao XL, Xiang YT, Zink M, Kane JM, Nielsen J, Leucht S, Correll CU. Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis. World Psychiatry. 2017 16(1):77-89.
  2. Alnæs D, Kaufmann T, van der Meer D, Córdova-Palomera A, Rokicki J, Moberget T, Bettella F, Agartz I, Barch DM, Bertolino A, Brandt CL, Cervenka S, Djurovic S, Doan NT, Eisenacher S, Fatouros-Bergman H, Flyckt L, Di Giorgio A, Haatveit B, Jönsson EG, Kirsch P, Lund MJ, Meyer-Lindenberg A, Pergola G, Schwarz E, Smeland OB, Quarto T, Zink M, Andreassen OA, Westlye LT, Karolinska Schizophrenia Project Consortium . Brain Heterogeneity in Schizophrenia and Its Association With Polygenic Risk. JAMA Psychiatry. 2019 76(7):739-748. Epub 2019 Apr 10.
  3. Weinbrenner A, Peus V, Inta D, Englisch S, Zink M. Risperidone-associated increase in triglyceride levels. Am J Psychiatry. 2009 166(1):113-4.
  4. Moberget T, Doan NT, Alnæs D, Kaufmann T, Córdova-Palomera A, Lagerberg TV, Diedrichsen J, Schwarz E, Zink M, Eisenacher S, Kirsch P, Jönsson EG, Fatouros-Bergman H, Flyckt L, KaSP , Pergola G, Quarto T, Bertolino A, Barch D, Meyer-Lindenberg A, Agartz I, Andreassen OA, Westlye LT. Cerebellar volume and cerebellocerebral structural covariance in schizophrenia: a multisite mega-analysis of 983 patients and 1349 healthy controls. Mol Psychiatry. 2018 23(6):1512-1520. Epub 2017 May 16.
  5. Zink M, Englisch S. Schizophrenia treatment: an obstacle course. Lancet Psychiatry. 2016 3(4):310-12. Epub 2016 Feb 24.


Zentralinstitut für Seelische Gesundheit (ZI) - https://www.zi-mannheim.de